AllQuantitative Report
logoArgusMarch 31, 2021

CHRS: What does Argus have to say about CHRS?

Symbols
CHRS
Sector(s)
Healthcare
Rating
Current Price
$14.14
Price Target
$NaN
Earnings Estimate

Coherus BioSciences Inc is a United States based biotherapeutics company engaged in developing and commercializing biosimilar therapeutics.

Quotes from this report
Symbol
NamePriceMarket CapPE Growth Rate(5Y)Net MarginEPS Growth(1Y)Argus Rating
CHRS
Coherus BioSciences, Inc.14.14N/AN/AN/AN/AN/A